查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
臨床腫瘤學下一代定序市場，按工作流程類型、技術、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1364700

臨床腫瘤學下一代定序市場，按工作流程類型、技術、按應用、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Clinical Oncology Next Generation Sequencing Market, By Workflow Type, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年臨床腫瘤學次世代定序市場規模為 3.884 億美元，2023 年至 2030 年年複合成長率為 16.5%。

臨床腫瘤學次世代定序市場-市場動態

癌症盛行率的上升預計將推動臨床腫瘤學下一代定序市場的成長。

隨著癌症盛行率的上升，人們更需要更好地了解這種疾病並發現新的藥物。次世代定序（NGS）檢測正迅速成為晚期癌症患者治療的首選。 NGS 檢測使用高通量 DNA 定序技術對完整基因組、完整外顯子組或某些基因外顯子（標靶組）進行定序。 2020年美國報告新增癌症病例1,603,844例，602,347人死於癌症。每10萬人中，新增癌症病例403例，144人死於癌症。根據疾病管制與預防中心的數據，2020 年是可取得發病率資料的最新一年。此外，次世代定序開啟了新的腫瘤學研究發現的大門，這可能會揭示新的癌症進展途徑和過程。它為市場提供了成長機會。然而，NGS 技術和基礎設施所需的初始投資成本高昂，可能會限制市場成長，

臨床腫瘤學下一代定序市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，全球臨床腫瘤下一代定序市場預計在預測期（2023-2030 年）每年將以 16.5% 左右的年複合成長率成長
  • 由於技術進步和研究支出的增加，預計臨床腫瘤學下一代定序市場將迅速擴大。
  • 根據工作流程細分，NGS 定序預計將在 2022 年顯示最大的市場佔有率
  • 從技術細分來看，標靶定序、重定序是2022年的主導類型
  • 從應用細分來看，2022年篩選為主導類型
  • 根據最終用戶細分，篩選是 2022 年的主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

臨床腫瘤學次世代定序市場細分分析：

全球臨床腫瘤學下一代定序市場根據工作流程類型、應用、技術、最終用戶和地區進行細分。

根據工作流程，市場分為三類： NGS預測序、NGS定序和NGS資料分析。 NGS 定序領域主導市場。 NGS 是指目前的一類定序技術，與舊方法相比，它可以實現更快、更便宜的 DNA 和 RNA 定序。這些技術能夠同時對數百萬至數十億個 DNA 分子進行定序。

根據技術，市場分為三類：全基因組定序、全外顯子定序以及標靶定序和重定序。靶向測序和重測序領域主導著市場成長。標靶定序不是對整個基因組進行定序，而是重點關注與疾病相關或懷疑與疾病相關的某些基因或感興趣的區域。對先前定序的 DNA 進行定序稱為重定序。目的是找到變體，特別是在感興趣的領域。

根據應用，市場分為兩類：篩檢、伴隨診斷和其他診斷。放映產業在市場中佔據主導地位，並可能在預測期內保持其主導地位。腫瘤和種系 DNA 的下一代定序 (NGS) 是精準腫瘤學的基礎，具有迅速擴展的診斷、預後和治療意義。 NGS 在腫瘤診斷和篩檢技術中的使用導致了市場的顯著擴張。對 NGS 面板、設備和相關服務的需求急劇增加。

根據最終用戶，市場分為三類：醫院、診所和實驗室。實驗室主導市場。許多診斷實驗室已經實施了NGS平台來提供腫瘤基因組分析，幫助醫生識別可操作的突變並相應地定製藥物。

臨床腫瘤學次世代定序市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。由於研發投資的增加以及癌症負擔的增加，預計北美將主導臨床腫瘤學下一代定序市場的成長。北美癌症發生率的增加需要新的診斷和治療方案。美國在醫療和生物技術研究方面投入大量資金。

公共和商業部門每年在研發上投資數十億美元，推動新技術的改進和接受。美國國家科學基金會國家科學與工程統計中心 (NCSES) 的最新資料顯示，2020 年美國的研究與實驗開發 (R&D) 總額達 7170 億美元。歐洲預計將成為第二大市場由於新醫療技術的日益普及，臨床腫瘤學一代定序。

臨床腫瘤學次世代定序市場-競爭格局：

下一代定序（NGS）技術的市場已大幅擴大。醫療保健領域的決策者需要了解市場成長和未來趨勢的事實知識，以便設計合適的策略和法規，但對這些模式的性質和規模知之甚少。公司經常透過合作或合併來提升自己的地位。主要公司正在將業務擴展到亞洲、拉丁美洲和非洲的新興國家，這些國家對現代醫療技術的需求不斷成長。此外，許多新創公司帶來了新的技術或方法，這可能會提供更快的定序、更高的準確性或更低的價格。例如，2022 年4 月12 日，Thermo Fisher Scientific 最近推出了帶有CE-IVD 標誌的Ion Torrent Genexus Dx 整合定序儀，這是一種自動化的下一代定序(NGS) 平台，可在一天內提供結果。

最近的發展：

2021 年 12 月，羅氏宣布推出 AVENIO Edge System，這是羅氏推進定序技術策略的核心組成部分。以一流的基礎功能為基礎，提供完全自動化的整合定序解決方案。羅氏致力於開發診斷解決方案，旨在為醫療保健界提供更快、更準確的醫療訊息，以預測風險和檢測疾病。

目錄

第 1 章：臨床腫瘤學下一代定序市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按工作流程類型分類的臨床腫瘤學下一代定序市場片段
    • 臨床腫瘤學次世代定序市場片段（按技術）
    • 臨床腫瘤學次世代定序市場片段（按應用）
    • 最終用戶的臨床腫瘤學下一代定序市場片段
    • 按國家/地區分類的臨床腫瘤學下一代定序市場片段
    • 按地區分類的臨床腫瘤學下一代定序市場片段
  • 競爭洞察

第 3 章：臨床腫瘤學下一代定序主要市場趨勢

  • 臨床腫瘤學次世代定序市場促進因素
    • 市場促進因素的影響分析
  • 臨床腫瘤學次世代定序市場限制
    • 市場限制影響分析
  • 臨床腫瘤學次世代定序市場機會
  • 臨床腫瘤學次世代定序市場未來趨勢

第 4 章：臨床腫瘤學下一代定序產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：臨床腫瘤學下一代定序市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：臨床腫瘤學下一代定序市場格局

  • 2022 年臨床腫瘤學下一代定序市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：臨床腫瘤學下一代定序市場 - 按工作流程類型

  • 概述
    • 按工作流程類型分類的細分市場佔有率分析
    • NGS預測序
    • NGS定序
    • NGS數據分析

第 8 章：臨床腫瘤學下一代定序市場 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 全基因組定序
    • 全外顯子定序
    • 標靶定序和重定序

第 9 章：臨床腫瘤學下一代定序市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 篩選
      • 散發性癌症
      • 遺傳性癌症
    • 伴隨診斷
    • 其他診斷

第 10 章：臨床腫瘤學下一代定序市場 - 按最終用戶

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 實驗室

第 11 章：臨床腫瘤學下一代定序市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 臨床腫瘤學下一代定序北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按工作流程類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲臨床腫瘤學下一代定序主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按工作流程類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區臨床腫瘤下一代定序主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依工作流程類型）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲臨床腫瘤學下一代定序主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按工作流程類型）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 臨床腫瘤學下一代定序中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按工作流程類型）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：關鍵供應商分析 - 臨床腫瘤學下一代定序產業

  • 競爭儀表板
  • 公司簡介
    • Illumina, Inc.
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche Ltd.
    • Agilent Technologies
    • Myriad Genetics
    • Foundation Medicine
    • Paradigm Diagnostics
    • Partek, Inc.
    • Pacific Bioscience
    • Qiagen NV
    • Beijing Genomics Institute (BGI)
    • Perkin Elmer
    • Oxford Nanopore Technologies Ltd.
    • Caris Life Sciences
    • Eurofins Scientific SE

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1748

REPORT HIGHLIGHT

Clinical Oncology Next Generation Sequencing Market size was valued at USD 388.4 Million in 2022, expanding at a CAGR of 16.5% from 2023 to 2030.

Next-generation sequencing (NGS), also known as massively parallel sequencing, is a powerful method for capturing a vast quantity of genomic information about a tumor. The majority of NGS technologies rely on synthesis-based sequencing. NGS has recently been used in clinical oncology to advance individualized cancer treatment. NGS is utilized to find familial cancer mutation carriers, identify novel and rare cancer mutations, and offer molecular rationale for effective targeted therapy. With targeted therapies becoming the new standard of care in oncology, NGS-driven companion diagnostics are generally expected to influence therapy selection to enhance patient outcomes.

Clinical Oncology Next Generation Sequencing Market- Market Dynamics

The rising prevalence of cancer is expected to drive the growth of the Clinical Oncology Next Generation Sequencing market.

As the prevalence of cancer rises, there is more need to better understand the disease and discover novel medicines. Next-generation sequencing (NGS) assays are quickly becoming the preferred option in the treatment of advanced cancer patients. NGS assays use high-throughput DNA sequencing technology to sequence the complete genome, the full exome, or certain gene exons (targeted panels). In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available, according to Centers for Disease Control and Prevention. Furthermore, Next Generation Sequencing opens the entrance to new oncological research discoveries, which may uncover new cancer progression pathways and processes. It provides growth opportunities for the market. However, the high cost of initial investment required for NGS technology and infrastructure can restrict market growth,

Clinical Oncology Next Generation Sequencing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Clinical Oncology Next Generation Sequencing market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2023-2030)
  • The Clinical Oncology Next Generation Sequencing market is predicted to expand rapidly as a result of growing technological advancements and increased research spending.
  • Based on Workflow segmentation, NGS Sequencing was predicted to show maximum market share in the year 2022
  • Based on Technology segmentation, Targeted Sequencing, and resequencing were the leading type in 2022
  • Based on Application segmentation, Screening was the leading type in 2022
  • Based on End-User segmentation, Screening was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Clinical Oncology Next Generation Sequencing Market- Segmentation Analysis:

The Global Clinical Oncology Next Generation Sequencing Market is segmented on the basis of Workflow Type, Application, Technology, End-User, and Region.

The market is divided into three categories based on Workflow: NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis. The NGS Sequencing segment dominates the market. NGS refers to a class of current sequencing technologies that enable significantly faster and less expensive DNA and RNA sequencing than older approaches. These technologies have the ability to sequence millions to billions of DNA molecules at the same time.

The market is divided into three categories based on Technology: Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing and resequencing. Targeted Sequencing and resequencing segment dominates the market growth. Rather than sequencing the entire genome, targeted sequencing focuses on certain genes or regions of interest that have been linked to disease or are suspected to be linked to disease. The sequencing of previously sequenced DNA is referred to as resequencing. The purpose is to find variants, particularly in areas of interest.

The market is divided into two categories based on application: Screening, Companion Diagnostics, and other diagnostics. The Screening sector dominates the market and is likely to maintain its dominance during the forecast period. Next-generation sequencing (NGS) of tumor and germline DNA is foundational for precision oncology, with rapidly expanding diagnostic, prognostic, and therapeutic implications. The use of NGS in oncology diagnostic and screening techniques has resulted in significant market expansion. The need for NGS panels, equipment, and related services has increased dramatically.

The market is divided into three categories based on End-User: Hospitals, Clinics, and Laboratories. Laboratories dominate the market. Many diagnostic laboratories have implemented NGS platforms to provide tumor genomic profiling, assisting doctors in identifying actionable mutations and tailoring medicines accordingly.

Clinical Oncology Next Generation Sequencing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Clinical Oncology next-generation Sequencing market, due to increasing R&D investment, and the Rising Burden of Cancer. The increased incidence of cancer in North America needs novel diagnostic and treatment options. The United States invests much in medical and biotechnology research.

Both the public and commercial sectors invest billions of dollars in R&D each year, fueling improvements and the acceptance of new technology. New data from the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation indicate that research and experimental development (R&D) performed in the United States totaled USD 717.0 billion in 2020. Europe is expected to be the second-largest market for Clinical Oncology Generation Sequencing, due to increasing penetration of new medical technologies.

Clinical Oncology Next Generation Sequencing Market- Competitive Landscape:

The market for next-generation sequencing (NGS) technologies has expanded substantially. Decision-makers in health care require factual knowledge of market growth and future trends in order to design suitable strategies and regulations, yet little is known about the nature and magnitude of these patterns. Companies frequently collaborate or merge to boost their position. Major firms are expanding their presence into emerging countries in Asia, Latin America, and Africa, where there is a growing demand for modern medical technologies. Also, a number of startups bring fresh technology or approaches to the table, which may offer faster sequencing, higher accuracy, or lower prices. For example, On April 12, 2022, Thermo Fisher Scientific recently launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in one day.

Recent Developments:

In December 2021, Roche nowadays announced the launch of the AVENIO Edge System, a core component of Roche's strategy to advance sequencing technologies. Built on best-in-class foundational capabilities to deliver a fully automated, integrated sequencing solution. Roche is committed to developing diagnostic solutions with the goal of providing the healthcare community with faster and more accurate medical information to predict risk and detect disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET KEY PLAYERS

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • Myriad Genetics
  • Foundation Medicine
  • Paradigm Diagnostics
  • Partek, Inc.
  • Pacific Bioscience
  • Qiagen N.V.
  • Beijing Genomics Institute (BGI)
  • Perkin Elmer
  • Oxford Nanopore Technologies Ltd.
  • Caris Life Sciences
  • Eurofins Scientific S.E.

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW TYPE

  • NGS Pre-Sequencing
  • NGS Sequencing
  • NGS Data Analysis

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing

GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • Screening
  • Sporadic Cancer
  • Inherited Cancer
  • Companion Diagnostics
  • Other Diagnostics

GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Laboratories

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Clinical Oncology Next Generation Sequencing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Oncology Next Generation Sequencing Market Snippet by Workflow Type
    • 2.1.2. Clinical Oncology Next Generation Sequencing Market Snippet by Technology
    • 2.1.3. Clinical Oncology Next Generation Sequencing Market Snippet by Application
    • 2.1.4. Clinical Oncology Next Generation Sequencing Market Snippet by End-User
    • 2.1.5. Clinical Oncology Next Generation Sequencing Market Snippet by Country
    • 2.1.6. Clinical Oncology Next Generation Sequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Oncology Next Generation Sequencing Key Market Trends

  • 3.1. Clinical Oncology Next Generation Sequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Oncology Next Generation Sequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Oncology Next Generation Sequencing Market Opportunities
  • 3.4. Clinical Oncology Next Generation Sequencing Market Future Trends

4. Clinical Oncology Next Generation Sequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Oncology Next Generation Sequencing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Oncology Next Generation Sequencing Market Landscape

  • 6.1. Clinical Oncology Next Generation Sequencing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Oncology Next Generation Sequencing Market - By Workflow Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow Type, 2022 & 2030 (%)
    • 7.1.2. NGS Pre-Sequencing
    • 7.1.3. NGS Sequencing
    • 7.1.4. NGS Data Analysis

8. Clinical Oncology Next Generation Sequencing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 8.1.2. Whole Genome Sequencing
    • 8.1.3. Whole Exome Sequencing
    • 8.1.4. Targeted Sequencing & Resequencing

9. Clinical Oncology Next Generation Sequencing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Screening
      • 9.1.2.1. Sporadic Cancer
      • 9.1.2.2. Inherited Cancer
    • 9.1.3. Companion Diagnostics
    • 9.1.4. Other Diagnostics

10. Clinical Oncology Next Generation Sequencing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Laboratories

11. Clinical Oncology Next Generation Sequencing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Clinical Oncology Next Generation Sequencing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Illumina, Inc.
    • 12.2.2. Thermo Fisher Scientific
    • 12.2.3. F. Hoffmann-La Roche Ltd.
    • 12.2.4. Agilent Technologies
    • 12.2.5. Myriad Genetics
    • 12.2.6. Foundation Medicine
    • 12.2.7. Paradigm Diagnostics
    • 12.2.8. Partek, Inc.
    • 12.2.9. Pacific Bioscience
    • 12.2.10. Qiagen N.V.
    • 12.2.11. Beijing Genomics Institute (BGI)
    • 12.2.12. Perkin Elmer
    • 12.2.13. Oxford Nanopore Technologies Ltd.
    • 12.2.14. Caris Life Sciences
    • 12.2.15. Eurofins Scientific S.E.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Clinical Oncology Next Generation Sequencing Market: Workflow Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Workflow Type
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Workflow Type 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Technology 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Application 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by End-User 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Clinical Oncology Next Generation Sequencing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Workflow Type segment market share analysis, 2022 & 2030
  • FIGURE Workflow Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Europe Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Asia Pacific Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Germany Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE India Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Brazil Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)